Background: The HLXB9 gene encodes a homeodomain containing transcription factor which has been implicated in the development of both solid and hematological malignancies. In leukemia it is one of the two fused genes, along with ETV6, in a recurrent translocation frequently observed in infant AML.
Procedure: Here we investigate the role of epigenetic inactivation of the HLXB9 gene in leukemia. Quantitative DNA methylation analysis was performed using the COBRA assay, and qRT-PCR was used to assess the effects of methylation on expression in hematological cell lines and primary ALL samples.
Results: Hypermethylation of the HLXB9 gene was found to be a frequent event in childhood ALL, occurring in 33% of cases. However, it was rarely or never observed in other types of leukemia, including AML, CML, and CLL, with the exception of adult ALL, in which 39% of cases were hypermethylated. Furthermore, hypermethylation of HLXB9 results in loss of expression in hematological cell lines and primary ALL samples.
Conclusion: These results suggest that HLXB9 may have a dual role in childhood leukemia, as an oncogene in infant AML but as a tumor suppressor in childhood ALL.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/pbc.22679 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Unraveling the interplay: exploring signaling pathways in pancreatic cancer in the context of pancreatic embryogenesis.
Front Cell Dev Biol
August 2024
Department of Anatomy, All India Institute of Medical Sciences, Bhubaneswar, India.
Pancreatic cancer continues to be a deadly disease because of its delayed diagnosis and aggressive tumor biology. Oncogenes and risk factors are being reported to influence the signaling pathways involved in pancreatic embryogenesis leading to pancreatic cancer genesis. Although studies using rodent models have yielded insightful information, the scarcity of human pancreatic tissue has made it difficult to comprehend how the human pancreas develops.
View Article and Find Full Text PDFCurrarino syndrome with immature teratoma: A case report with review of literature.
J Cancer Res Ther
April 2024
Department of Pediatric Surgery, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India.
Currarino syndrome (CS) is a rare congenital syndrome characterized by a triad of anorectal malformation, sacral deformity, and presacral mass. In about 50% of cases, it is caused by HLXB9 gene mutation in chromosome 7q36. A 13-month-male child presented with presacral discharging sinus with a history of surgery for anorectal malformation and perineal fistula at the time of birth.
View Article and Find Full Text PDFCase Report: Congenital Brain Dysplasia, Developmental Delay and Intellectual Disability in a Patient With a 7q35-7q36.3 Deletion.
Front Genet
December 2021
Department of Nephrology, The Third Xiangya Hospital of Central South University, Changsha, China.
7q terminal deletion syndrome is a rare condition presenting with multiple congenital malformations, including abnormal brain and facial structures, developmental delay, intellectual disability, abnormal limbs, and sacral anomalies. At least 40 OMIM genes located in the 7q34-7q36.3 region act as candidate genes for these phenotypes, of which , , , , , , and may be the most important.
View Article and Find Full Text PDFThe first case of mosaic MNX1 mutation in an adult female with features of Currarino syndrome.
Birth Defects Res
September 2021
UOC Genetica Medica, Istituto Giannina Gaslini, Genoa, Italy.
Article Synopsis
- Currarino syndrome (CS) is a rare genetic disorder marked by anorectal malformation, sacro-coccygeal bone defects, and presacral masses, often seen more in females who may also face gynecologic and urinary issues.
- The condition is linked to mutations in the MNX1 gene on chromosome 7q36, with the majority of familial cases showing heterozygous loss-of-function mutations, while about 30% of sporadic cases do.
- A unique case is discussed where a woman with CS has a mosaic mutation in the MNX1 gene, highlighting that such mutations could also explain the lower detection rates in sporadic cases through mechanisms like somatic mosaicism.
Differentiation of Motor Neuron-Like Cells from Tonsil-Derived Mesenchymal Stem Cells and Their Possible Application to Neuromuscular Junction Formation.
Int J Mol Sci
June 2019
Department of Biochemistry, College of Medicine, Ewha Womans University, Seoul 07804, Korea.
Human tonsil-derived mesenchymal stem cells (T-MSCs) are newly identified MSCs and present typical features of MSCs, including having the differentiation capacity into the three germ layers and excellent proliferation capacity. They are easily sourced and are useful for stem cell therapy in various disease states. We previously reported that T-MSCs could be differentiated into skeletal myocytes and Schwann-like cells; therefore, they are a promising candidate for cell therapies for neuromuscular disease.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!